ArticleBMC veterinary research2025
Establishment and application of a visual nucleic acid detection method for parvovirus.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Parvoviruses pose a significant threat to the livestock breeding industry, leading to high morbidity and mortality rates. Rapid, accurate, and convenient detection methods are crucial for early intervention and control of parvovirus infection. This study established a novel visualized parvovirus detection method based on nucleic acid-mismatched enzyme detection—NMED. This method targets a conserved region of the Canine Parvo Virus (CPV) VP2 gene by utilizing specific fluorescent reporter probes and Recombinant Polymerase Amplification༈RPA༉ primers. Upon recognition of the target sequence by the reporter probe, T7 endonuclease Ⅰ (T7E Ⅰ) is activated, cleaving the probe and enabling detection under UV light or via the use of a fluorescence reader. Our research results show that we have successfully established a novel nucleic acid-based method for detecting CPV. This method can detect nucleic acid within 50 min. It exhibits high specificity, demonstrating no cross-reactivity with common canine pathogens. The method has a lower limit of detection of 1–10 copies/µL. The three replicates consistently yielded identical results, indicating high stability. Compared with qPCR, the NMED method achieved a concordance rate of 90.63%—93.75% for 32 suspected CPV samples. In conclusion, this study developed a convenient, efficient, visual nucleic acid detection method for CPV. The establishment of NMED has provided a new method for detecting parvovirus, which is highly important for the timely prevention and control of parvovirus infection and the reduction of livestock mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.